Group 1 - The company reported a revenue of HKD 2.279 billion for the year ending December 31, 2025, representing a year-on-year increase of 13.86% [1] - The net profit for the year was HKD 156 million, a significant decrease of 79.69% compared to the previous year [1] - Basic earnings per share were reported at 1.4 HK cents [1] Group 2 - The company maximized production capacity for its amino acid business, resulting in a sales volume increase of approximately 36.6% to 522,000 metric tons, up from 382,000 metric tons in 2024 [1] - Due to intense domestic market competition, local suppliers are shifting to sell amino acid products in the domestic market [1] - The company plans to adjust amino acid production in the fourth quarter of 2025 to achieve optimal production rates in response to the oversupply of amino acid products in China [1]
大成生化科技(00809)发布年度业绩，年度溢利1.56亿港元 同比减少79.69%